Dr. Ross on the Treatment of Liver Metastasis in Melanoma

Merrick I. Ross, MD
Published: Friday, Jun 30, 2017



Merrick I. Ross, MD, professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses treatment for liver metastasis in patients with melanoma.

Liver metastasis is a very difficult problem for a variety of reasons, explains Ross. It’s possible that the active immunotherapy agents may not be as effective in the liver.

Of the patients who have metastatic disease, 95% of them will have some component of liver metastasis, states Ross.

<<< View more from the European Post-Chicago Meeting


Merrick I. Ross, MD, professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses treatment for liver metastasis in patients with melanoma.

Liver metastasis is a very difficult problem for a variety of reasons, explains Ross. It’s possible that the active immunotherapy agents may not be as effective in the liver.

Of the patients who have metastatic disease, 95% of them will have some component of liver metastasis, states Ross.

<<< View more from the European Post-Chicago Meeting



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Advances in™ Melanoma: Exploring BRAF/MEK in Adjuvant and Neoadjuvant SettingsSep 28, 20191.5
Medical Crossfire®: What Does Data Tell Us About How to Optimize Checkpoint Inhibitor Strategies Across Lines of Care for Patients with Melanoma?Nov 30, 20191.5
Publication Bottom Border
Border Publication
x